Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Oncogenesis ; 6(1): e295, 2017 Jan 30.
Article in English | MEDLINE | ID: mdl-28134933

ABSTRACT

Integrins, a family of heterodimeric receptors for extracellular matrix, are promising therapeutic targets for ovarian cancer, particularly high-grade serous-type (HGSOC), as they drive tumor cell attachment, migration, proliferation and survival by activating focal adhesion kinase (FAK)-dependent signaling. Owing to the potential off-target effects of FAK inhibitors, disruption of the integrin signaling axis remains to be a challenge. Here, we tackled this barrier by screening for inhibitors being functionally cooperative with small-molecule VS-6063, a phase II FAK inhibitor. From this screening, JQ1, a potent inhibitor of Myc oncogenic network, emerged as the most robust collaborator. Treatment with a combination of VS-6063 and JQ1 synergistically caused an arrest of tumor cells at the G2/M phase and a decrease in the XIAP-linked cell survival. Our subsequent mechanistic analyses indicate that this functional cooperation was strongly associated with the concomitant disruption of activation or expression of FAK and c-Myc as well as their downstream signaling through the PI3K/Akt pathway. In line with these observations, we detected a strong co-amplification or upregulation at genomic or protein level for FAK and c-Myc in a large portion of primary tumors in the TCGA or a local HGSOC patient cohort. Taken together, our results suggest that the integrin-FAK signaling axis and c-Myc synergistically drive cell proliferation, survival and oncogenic potential in HGSOC. As such, our study provides key genetic, functional and signaling bases for the small-molecule-based co-targeting of these two distinct oncogenic drivers as a new line of targeted therapy against human ovarian cancer.

2.
Hum Exp Toxicol ; 21(2): 91-7, 2002 Feb.
Article in English | MEDLINE | ID: mdl-12102503

ABSTRACT

Much confusion surrounds the concept of hormesis and what its biological meaning represents. This paper provides a definition of hormesis that addresses its historical foundations, quantitative features, and underlying evolutionary and toxicologically based mechanistic strategies. Hormesis should be considered an adaptive response characterized by biphasic dose responses of generally similar quantitative features with respect to amplitude and range of the stimulatory response that are either directly induced or the result of compensatory biological processes following an initial disruption in homeostasis. Given the limited magnitude of the stimulatory response (i.e., usually 30-60% greater than controls at maximum), heightened study design and replication requirements are often necessary to ensure reliable judgments on causality. Even though hormesis is considered an adaptive response, the issue of beneficial/harmful effects should not be part of the definition of hormesis, but reserved to a subsequent evaluation of the biological and ecological context of the response.


Subject(s)
Adaptation, Physiological/physiology , Homeostasis/physiology , Adaptation, Physiological/drug effects , Adaptation, Physiological/radiation effects , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Homeostasis/drug effects , Homeostasis/radiation effects , Humans
3.
Crit Rev Toxicol ; 31(4-5): 353-424, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11504172

ABSTRACT

The present article represents a comprehensive effort to assess the hypothesis that hormesis is a highly generalizable biological phenomenon independent of environmental stressor, biological endpoint, and experimental model system. The evaluative methodology and complementary approaches employed to assess this question are (1) evolutionary biology-based theoretical paradigm; (2) evaluation of > 20,000 toxicology articles using a priori entry and evaluative criteria; (3) evaluation of 17 large-scale studies each providing data on numerous agents tested in the same experimental model by the same research team; (4) the assimilation of experimental pharmacological data on 24 receptor systems in which biphasic dose responses have been established reproducibly along with hormetic mechanism elucidation; and (5) assessment of the original hormesis database with 1600 dose-response relationships demonstrating evidence consistent with the hormesis hypothesis. The complementary approaches for assessing hormesis provided strong support for its credibility as a central biological theory based on its high frequency of occurrence and quantitative features of expression within microbe, plant, and invertebrate and vertebrate animal systems. The findings suggest that hormetic effects represent evolutionary-based adaptive responses to environmentally induced disruptions in homeostasis. Such adaptive responses, which are incorporated into organismal integrative physiological systems and now clarified at the mechanistic level for more than two dozen receptor systems, provide a cogent basis for the application of hormetic mechanisms in the elucidation of fundamental evolutionary-based biological processes and in the development of novel clinical modalities.


Subject(s)
Adaptation, Physiological , Biological Evolution , Dose-Response Relationship, Drug , Homeostasis/physiology , Models, Biological , Animals , Databases, Factual , Humans , Invertebrates , Plants , Terminology as Topic , Toxicity Tests , Vertebrates
4.
Crit Rev Toxicol ; 31(4-5): 471-3, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11504174

ABSTRACT

This article proposes a general mechanism by which biphasic dose-response relationships occur in pharmacological and toxicological experimental systems. Such biphasic responses are mediated via a strategy of differential binding to stimulatory and inhibitory receptor subtypes based on agonist concentrations. Such a strategy is widely seen in pharmacological systems and has been demonstrated in toxicological-related biphasic dose responses in which the treatment altered levels of endogenous agonists.


Subject(s)
Adaptation, Physiological , Dose-Response Relationship, Drug , Homeostasis , Pharmacology , Animals , Humans , Models, Theoretical , Signal Transduction , Toxicity Tests
6.
Toxicol Sci ; 62(2): 330-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11452146

ABSTRACT

Hormesis has been defined as a dose-response relationship in which there is a stimulatory response at low doses, but an inhibitory response at high doses, resulting in a U- or inverted U-shaped dose response. To assess the proportion of studies satisfying criteria for evidence of hormesis, a database was created from published toxicological literature using rigorous a priori entry and evaluative criteria. One percent (195 out of 20,285) of the published articles contained 668 dose-response relationships that met the entry criteria. Subsequent application of evaluative criteria revealed that 245 (37% of 668) dose-response relationships from 86 articles (0.4% of 20,285) satisfied requirements for evidence of hormesis. Quantitative evaluation of false-positive and false-negative responses indicated that the data were not very susceptible to such influences. A complementary analysis of all dose responses assessed by hypothesis testing or distributional analyses, where the units of comparison were treatment doses below the NOAEL, revealed that of 1089 doses below the NOAEL, 213 (19.5%) satisfied statistical significance or distributional data evaluative criteria for hormesis, 869 (80%) did not differ from the control, and 7 (0.6%) displayed evidence of false-positive values. The 32.5-fold (19.5% vs 0.6%) greater occurrence of hormetic responses than a response of similar magnitude in the opposite (negative) direction strongly supports the nonrandom nature of hormetic responses. This study, which provides the first documentation of a data-derived frequency of hormetic responses in the toxicologically oriented literature, indicates that when the study design satisfies a priori criteria (i.e., a well-defined NOAEL, > or = 2 doses below the NOAEL, and the end point measured has the capacity to display either stimulatory or inhibitory responses), hormesis is frequently encountered and is broadly represented according to agent, model, and end point. These findings have broad-based implications for study design, risk assessment methods, and the establishment of optimal drug doses and suggest important evolutionarily adaptive strategies for dose-response relationships.


Subject(s)
Dose-Response Relationship, Drug , Toxicology , False Negative Reactions , False Positive Reactions , No-Observed-Adverse-Effect Level
7.
Trends Pharmacol Sci ; 22(6): 285-91, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11395156

ABSTRACT

The fundamental nature of the dose response is neither linear or threshold, but rather U-shaped. When studies are properly designed to evaluate biological activity below the traditional toxicological threshold, low-dose stimulatory responses are observed with high frequency and display specific quantitative features. With a few exceptions, the low-dose stimulatory response is usually not more than twofold greater than the control response, with a stimulatory zone that is more variable, ranging from less than tenfold to more than several orders of magnitude of the dose. Considerable mechanistic evidence indicates that hormetic effects represent overcompensation in response to disruptions in homeostasis that are mediated by agonist concentration gradients with different affinities for stimulatory and inhibitory regulatory pathways.


Subject(s)
Dose-Response Relationship, Drug , Toxicology/methods , Animals , Databases, Factual , Hazardous Substances/pharmacology , Humans
8.
Annu Rev Public Health ; 22: 15-33, 2001.
Article in English | MEDLINE | ID: mdl-11274508

ABSTRACT

The occurrence of U-shaped dose-response relationships (often termed hormesis) has been documented in numerous biological, toxicological, and pharmacological investigations. Many of the endpoints studied are of considerable significance to public health (e.g. body weight, cholesterol levels, ethanol consumption, longevity, cancer incidence, etc). Despite the fact that U-shaped dose-responses are widely and independently observed, little attempt has been made to assess this phenomenon in an integrative manner. This review provides an overview of the historical foundations of hormesis and a discussion of its definition within a mechanistic framework. The occurrence, generalizability, and biological significance of U-shaped dose-response relationships along with the concept of biological optimality are addressed.


Subject(s)
Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Models, Biological , Databases, Factual , Environmental Health/statistics & numerical data , History, 20th Century , Humans , Toxicology/history , Toxicology/statistics & numerical data
9.
Hum Exp Toxicol ; 19(1): 2-31, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10745292

ABSTRACT

Despite the long history of hormesis-related experimental research no systematic effort to describe its early history has been undertaken. The present paper attempts to reconstruct and assess the early history of such research and to evaluate how advances in related scientific fields affected the course of hormesis-related research. The purpose of this paper is not only to satisfy this gap in current knowledge, but also to provide a foundation for the assessment of how the concept of hormetic dose-response relationships may have affected the nature of the bioassay especially with respect to hazard assessment practices within a modern risk assessment framework.


Subject(s)
Endocrine System/drug effects , Environmental Pollutants/pharmacology , Xenobiotics/pharmacology , Adaptation, Physiological , Bacterial Physiological Phenomena , Dose-Response Relationship, Drug , Fungi/physiology , Humans , Plant Physiological Phenomena , Risk Assessment , Yeasts/physiology
10.
Hum Exp Toxicol ; 19(1): 41-75, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10745294

ABSTRACT

This paper represents the first systematic effort to describe the historical foundations of radiation hormesis. Spanning the years from 1898 to the early 1940's the paper constructs and assesses the early history of such research and evaluates how advances in related scientific fields affected the course of hormetic related research. The present effort was designed to not only address this gap in current knowledge, but to offer a toxicological basis for how the concept of hormetic dose-response relationships may affect the nature of the bioassay and its role in the risk assessment process.


Subject(s)
Radiation Injuries/history , Radiation, Ionizing , Radiation, Nonionizing/adverse effects , Toxicology/history , Animals , Bacteria , Biological Assay/history , Biological Assay/methods , Dose-Response Relationship, Radiation , Fungi , History, 19th Century , History, 20th Century , Humans , Insecta , Radiation Injuries/physiopathology , Radiometry/history , Reproducibility of Results , Risk Assessment
11.
Hum Exp Toxicol ; 19(1): 32-40, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10745293

ABSTRACT

Despite the substantial development and publication of highly reproducible toxicological data, the concept of hormetic dose-response relationships was never integrated into the mainstream of toxicological thought. Review of the historical foundations of the interpretation of the bioassay and assessment of competitive theories of dose-response relationships lead to the conclusion that multiple factors contributed to the marginalization of hormesis during the middle and subsequent decades of the 20th century. These factors include: (a) the close-association of hormesis with homeopathy lead to the hostility of modern medicine toward homeopathy thereby creating a guilt by association framework, and the carry-over influence of that hostility in the judgements of medically-based pharmacologists/ toxicologists toward hormesis; (b) the emphasis of high dose effects linked with a lack of appreciation of the significance of the implications of low dose stimulatory effects; (c) the lack of an evolutionary-based mechanism(s) to account for hormetic effects; and (d) the lack of appropriate scientific advocates to counter aggressive and intellectually powerful critics of the hormetic perspective.


Subject(s)
Environmental Pollutants/pharmacology , Homeopathy , Toxicology/trends , Animals , Biological Evolution , Dose-Response Relationship, Drug , Health Knowledge, Attitudes, Practice , Humans , Reproducibility of Results
12.
Hum Exp Toxicol ; 19(1): 76-84, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10745295

ABSTRACT

This paper examines the underlying factors that contributed to the marginalization of radiation hormesis in the early and middle decades of the 20th century. The most critical factor affecting the demise of radiation hormesis was a lack of agreement over how to define the concept of hormesis and quantitatively describe its dose-response features. If radiation hormesis had been defined as a modest overcompensation to a disruption in homeostasis as would have been consistent with the prevailing notion in the area of chemical hormesis, this would have provided the theoretical and practical means to blunt subsequent legitimate criticism of this hypothesis. A second critical factor undermining the radiation hormesis hypothesis was the generally total lack of recognition by radiation scientists of the concept of chemical hormesis which was markedly more advanced, substantiated and generalized than in the radiation domain. The third factor was that major scientific criticism of low dose stimulatory responses was galvanized at the time that the National Research Council (NRC) was organizing a national research agenda on radiation and the hormetic hypothesis was generally excluded from the future planned research opportunities. Furthermore, the criticisms of the leading scientists of the 1930s which undermined the concept of radiation hormesis were limited in scope and highly flawed and then perpetuated over the decades by other 'prestigious' experts who appeared to simply accept the earlier reports. This setting was then linked to a growing fear of radiation as a cause of birth defects, mutation and cancer, factors all reinforced by later concerns over the atomic bomb. Strongly supportive findings on hormetic effects in the 1940s by Soviet scientists were either generally not available to US scientists or disregarded as part of the Cold War mindset without adequate analysis. Finally, a massive, but poorly designed, US Department of Agriculture experiment in the late 1940s to assess the capacity for low dose plant stimulation by radionuclides failed to support the hormetic hypothesis thereby markedly lessening enthusiasm for research and funding in this area. Thus, the combination of a failed understanding of the hormetic hypothesis and its linkage with a strong chemical hormesis database, flawed analyses by prestigious scientists at the critical stage of scientific research development, reinforced by a Cold War mentality led to marginalization of an hypothesis (i.e., radiation hormesis) that had substantial scientific foundations and generalizability.


Subject(s)
Radiation Injuries/history , Toxicology/history , Adaptation, Physiological , Congenital Abnormalities/etiology , Congenital Abnormalities/history , Dose-Response Relationship, Radiation , Health Knowledge, Attitudes, Practice , History, 20th Century , Humans , Models, Theoretical , Politics , Radiation Injuries/physiopathology , Social Conditions/history
13.
Hum Exp Toxicol ; 19(1): 85-97, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10745296

ABSTRACT

This paper compares the historical developments of chemical and radiation hormesis from their respective inceptions in the late 1880's for chemical hormesis and early 1900's for radiation hormesis to the mid 1930's to 1940 during which both hypotheses rose to some prominence but then became marginalized within the scientific community. This analysis documents that there were marked differences in their respective temporal developments, and the direction and maturity of research. In general, the formulation of the chemical hormesis hypothesis displayed an earlier, more-extensive and more sophisticated development than the radiation hormesis hypothesis. It was able to attract prestigious researchers with international reputations from leading institutions, to be the subject of numerous dissertations, to have its findings published in leading journals, and to have its concepts incorporated into leading microbiological texts. While both areas became the object of criticism from leading scientists, the intensity of the challenge was greatest for chemical hormesis due to its more visible association with the medical practice of homeopathy. Despite the presence of legitimate and flawed criticism, the most significant limitations of both chemical and radiation hormesis and their respective ultimate undoing were due to their: (1) lack of development of a coherent dose-response theory using data of low dose stimulation from both the chemical and radiation domains; (2) difficulty in replication of low dose stimulatory responses without an adequate study design especially with respect to an appropriate number and properly spaced doses below the toxic threshold; (3) modest degree of stimulation even under optimal conditions which was difficult to distinguish from normal variation; and (4) lack of appreciation of the practical and/or commercial applications of the concepts of low dose stimulation.


Subject(s)
Radiation Injuries/history , Toxicology/history , Xenobiotics/history , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Health Knowledge, Attitudes, Practice , History, 19th Century , History, 20th Century , Humans , Models, Theoretical , Radiation Injuries/physiopathology , Reproducibility of Results , Research Design , Xenobiotics/administration & dosage , Xenobiotics/pharmacology
14.
Biogerontology ; 1(4): 309-19, 2000.
Article in English | MEDLINE | ID: mdl-11708212

ABSTRACT

A number of animal model studies have assessed the capacity of long-term whole body gamma rays to affect life span. The initial goal of such studies was to establish the equivalent of a no observed adverse effects level (NOAEL) that would provide a toxicological foundation for deriving an acceptable worker exposure standard. In the course of initial studies to establish such a 'tolerance threshold', data emerged suggesting that low dose rates/cumulative doses enhanced longevity in mice and guinea pigs of both sexes. Extensive large scale follow-up investigations with other mouse strains and rats revealed what appear to be inter-strain/species differences in response with some models providing strong evidence for a low dose increase in longevity. The subsequent positive studies in mouse models were generally well designed, well conducted and used extensive numbers of mice. In all experiments that displayed enhanced longevity the average life span was enhanced by 10-30% but not the maximum life span potential. The underlying mechanisms affecting the apparent enhancement in longevity are believed to result from the stimulation of hematopoietic and immune systems following an initial low level chronic injury to the bone marrow.


Subject(s)
Longevity/radiation effects , Animals , Gamma Rays , Humans , Longevity/immunology , Longevity/physiology , Mice , Rats
15.
Toxicol Pathol ; 27(2): 187-94, 1999.
Article in English | MEDLINE | ID: mdl-10207983

ABSTRACT

Despite the substantial development and publication of highly reproducible toxicological data, the concept of hormetic dose-response relationships was never integrated into the mainstream of toxicological thought. Review of the historical foundations of the interpretation of the bioassay and assessment of competitive theories of dose-response relationships lead to the conclusion that multiple factors contributed to the marginalization of hormesis during the middle and subsequent decades of the 20th Century. These factors include the following: (a) the close association of hormesis with homeopathy, which led to the hostility of modern medicine toward homeopathy, thereby creating a guilt-by-association framework, and the carryover influence of that hostility toward hormesis in the judgements of medically based pharmacologists/toxicologists; (b) the emphasis of high-dose effects linked with a lack of appreciation of the significance of the implications of low-dose stimulatory effects; (c) the lack of an evolution-based mechanism(s) to account for hormetic effects; and (d) lack of appropriate scientific advocates to counter aggressive and intellectually powerful critics of the hormetic perspective.


Subject(s)
Dose-Response Relationship, Drug , Hazardous Substances/toxicity , Animals , Humans , No-Observed-Adverse-Effect Level , Toxicity Tests
16.
Toxicol Pathol ; 27(2): 195-216, 1999.
Article in English | MEDLINE | ID: mdl-10207984

ABSTRACT

Despite the long history of hormesis-related experimental research, no systematic effort to describe its early history has been undertaken. The present paper attempts to reconstruct and assess the early history of such research and to evaluate how advances in related scientific fields affected the course of hormesis-related research. The purpose of this paper is not only to satisfy this gap in current knowledge but also to provide a foundation for the assessment of how the concept of hormetic dose-response relationships may have affected the nature of the bioassay, especially with respect to hazard assessment practices within a modern risk assessment framework.


Subject(s)
Dose-Response Relationship, Drug , Hazardous Substances/history , Animals , Hazardous Substances/toxicity , History, 19th Century , History, 20th Century , Humans , No-Observed-Adverse-Effect Level , Toxicity Tests/history , Toxicology/history
17.
Risk Anal ; 19(2): 261-81, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10765404

ABSTRACT

From a comprehensive search of the literature, the hormesis phenomenon was found to occur over a wide range of chemicals, taxonomic groups, and endpoints. By use of computer searches and extensive cross-referencing, nearly 3000 potentially relevant articles were identified. Evidence of chemical and radiation hormesis was judged to have occurred in approximately 1000 of these by use of a priori criteria. These criteria included study design features (e.g., number of doses, dose range), dose-response relationship, statistical analysis, and reproducibility of results. Numerous biological endpoints were assessed, with growth responses the most prevalent, followed by metabolic effects, reproductive responses, longevity, and cancer. Hormetic responses were generally observed to be of limited magnitude with an average maximum stimulation of 30 to 60 percent over that of the controls. This maximum usually occurred 4- to 5-fold below the NOAEL for a particular endpoint. The present analysis suggests that hormesis is a reproducible and generalizable biological phenomenon and is a fundamental component of many, if not most, dose-response relationships. The relatively infrequent observation of hormesis in the literature is believed to be due primarily to experimental design considerations, especially with respect to the number and range of doses and endpoint selection. Because of regulatory considerations, most toxicologic studies have been carried out at high doses above the low-dose region where the hormesis phenomenon occurs.


Subject(s)
Dose-Response Relationship, Drug , Risk Assessment , Toxicology , Animals , Carcinogens/adverse effects , Dose-Response Relationship, Radiation , Growth/drug effects , Humans , Longevity/drug effects , Metabolism/drug effects , Neoplasms/chemically induced , Neoplasms, Experimental/chemically induced , No-Observed-Adverse-Effect Level , Reproducibility of Results , Reproduction/drug effects , Research Design , Statistics as Topic
19.
Hum Exp Toxicol ; 17(7): 353-64, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9726531

ABSTRACT

The development of a comprehensive database of chemical hormetic responses (i.e., U- or inverted U-shaped dose-response relationships) using objective a priori study design, statistical and study replication criteria has recently been reported. An assessment of this database reveals the existence of a wide range of hormetic dose-response relationships including those demonstrating a direct stimulation or an overcompensation response to a disruption of homeostasis. These two broad types of hormetic responses are affected by temporal factors and display unique patterns of dose-range stimulation, magnitude of stimulatory response and relationship of the maximum stimulatory response to the NOAEL. A general classification of U-shaped dose-response relationships is proposed to provide a more organized framework to evaluate the highly distinctive and diverse hormetic responses within the context of establishing underlying biological mechanisms and exploring risk assessment implications.


Subject(s)
Risk Assessment/methods , Toxicity Tests/methods , Animals , Databases, Factual , Dose-Response Relationship, Drug , Humans , Models, Statistical
20.
Environ Health Perspect ; 106 Suppl 1: 357-62, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9539030

ABSTRACT

A comprehensive effort was undertaken to identify articles demonstrating chemical hormesis. Nearly 4000 potentially relevant articles were retrieved from preliminary computer database searches by using various key word descriptors and extensive cross-referencing. A priori evaluation criteria were established including study design features (e.g., number of doses, dose range), statistical analysis, and reproducibility of results. Evidence of chemical hormesis was judged to have occurred in approximately 350 of the 4000 studies evaluated. Chemical hormesis was observed in a wide range of taxonomic groups and involved agents representing highly diverse chemical classes, many of potential environmental relevance. Numerous biological end points were assessed; growth responses were the most prevalent, followed by metabolic effects, longevity, reproductive responses, and survival. Hormetic responses were generally observed to be of limited magnitude. The average low-dose maximum stimulation was approximately 50% greater than controls. The hormetic dose-response range was generally limited to about one order of magnitude, with the upper end of the hormetic curve approaching the estimated no observable effect level for the particular end point. Based on the evaluation criteria, high to moderate evidence of hormesis was observed in studies comprised of > 6 doses; with > 3 doses in the hormetic zone. The present analysis suggests that chemical hormesis is a reproducible and relatively common biological phenomenon. A quantitative scheme is presented for future application to the database.


Subject(s)
Dose-Response Relationship, Drug , Toxicology , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...